De Rosch Mark — SEC insider filings

SEC reporting owner CIK 1890320. 5 insider filings on record with FilingPulse; latest filed 2026-10-23.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2021-10-29 to 2026-10-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aura Biosciences, Inc. (AURA)Chief Operating Officer3—1 leg · 1,115 sh · $13,8904
CervoMed Inc. (CRVO)EVP, RA and GA and PgM2——2

Insider filings — De Rosch Mark

FiledFormIssuerReported transactionsSource
2026-10-234CervoMed Inc. (CRVO)Grant/award (A): 19,100 (derivative) @ $0EDGAR
2026-02-134CervoMed Inc. (CRVO)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-01-234Aura Biosciences, Inc. (AURA)Grant/award (A): 42,250 @ $0 · Grant/award (A): 65,000 (derivative)EDGAR
2022-11-024Aura Biosciences, Inc. (AURA)Sale (S): 1,115 @ $12.46EDGAR
2021-10-294Aura Biosciences, Inc. (AURA)Grant/award (A): 17,500 @ $0 · Grant/award (A): 75,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-10-27 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1890320 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs